Enteropathy-associated T-cell lymphoma secondary prevention: Difference between revisions
Nima Nasiri (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Enteropathy-associated T-cell lymphoma}} | |||
{{CMG}} {{AE}}{{Nnasiri}} | |||
==Overview== | ==Overview== | ||
Enteropathy-associated T-cell Lymphoma (EATL), also enteropathy-type T-cell lymphoma (ETTL), is a type of T-cell non-hodgkin lymphoma that affects the [[small intestine]], it is composed of large lymphoid cells. Enteropathy-associated T-cell lymphoma has two subtypes, type I enteropathy-associated T-cell lymphoma which has a strong association with [[celiac disease]] and it is more common in western countries and type II enteropathy-associated T-cell lymphoma which is mostly found among the Asian population. [[Genes]] involved in the [[pathogenesis]] of this disease include 8q24, T-cell receptor (TCR) beta and gamma, and 16q genes. There are no established causes for enteropathy-associated T-cell lymphoma. EATL must be differentiated from other diseases such as [[peptic ulcer]], poorly-differentiated adenocarcinoma, [[MALT lymphoma]], [[diffuse large B cell lymphoma]], and [[mantle cell lymphoma]]. | Enteropathy-associated T-cell Lymphoma (EATL), also enteropathy-type T-cell lymphoma (ETTL), is a type of T-cell non-hodgkin lymphoma that affects the [[small intestine]], it is composed of large lymphoid cells. Enteropathy-associated T-cell lymphoma has two subtypes, type I enteropathy-associated T-cell lymphoma which has a strong association with [[celiac disease]] and it is more common in western countries and type II enteropathy-associated T-cell lymphoma which is mostly found among the Asian population. [[Genes]] involved in the [[pathogenesis]] of this disease include 8q24, T-cell receptor (TCR) beta and gamma, and 16q genes. There are no established causes for enteropathy-associated T-cell lymphoma. EATL must be differentiated from other diseases such as [[peptic ulcer]], poorly-differentiated adenocarcinoma, [[MALT lymphoma]], [[diffuse large B cell lymphoma]], and [[mantle cell lymphoma]]. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no established measures for the secondary prevention of enteropathy-associated T cell lymphoma. | There are no established measures for the secondary prevention of enteropathy-associated T cell lymphoma. | ||
Revision as of 13:12, 8 March 2019
|
Enteropathy-associated T-cell lymphoma Microchapters |
|
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Enteropathy-associated T-cell lymphoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma secondary prevention |
|
FDA on Enteropathy-associated T-cell lymphoma secondary prevention |
|
CDC on Enteropathy-associated T-cell lymphoma secondary prevention |
|
Enteropathy-associated T-cell lymphoma secondary prevention in the news |
|
Blogs on Enteropathy-associated T-cell lymphoma secondary prevention |
|
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
Enteropathy-associated T-cell Lymphoma (EATL), also enteropathy-type T-cell lymphoma (ETTL), is a type of T-cell non-hodgkin lymphoma that affects the small intestine, it is composed of large lymphoid cells. Enteropathy-associated T-cell lymphoma has two subtypes, type I enteropathy-associated T-cell lymphoma which has a strong association with celiac disease and it is more common in western countries and type II enteropathy-associated T-cell lymphoma which is mostly found among the Asian population. Genes involved in the pathogenesis of this disease include 8q24, T-cell receptor (TCR) beta and gamma, and 16q genes. There are no established causes for enteropathy-associated T-cell lymphoma. EATL must be differentiated from other diseases such as peptic ulcer, poorly-differentiated adenocarcinoma, MALT lymphoma, diffuse large B cell lymphoma, and mantle cell lymphoma.
Secondary Prevention
There are no established measures for the secondary prevention of enteropathy-associated T cell lymphoma.